Company Filing History:
2 out of 3,923 
2 out of 68 
Years Active: 2012-2013
Title: Weijia Zheng: Innovator in Pharmaceutical Chemistry
Introduction
Weijia Zheng is a prominent inventor based in Cambridge, MA, known for her contributions to pharmaceutical chemistry. With a focus on innovative formulations and salt forms of compounds, she has made significant strides in the field of medicinal chemistry. Her work is particularly relevant in the development of treatments for disorders mediated by Hsp90.
Latest Patents
Weijia Zheng holds 2 patents, with her latest inventions focusing on acid addition salts, hydrates, and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide. These patents detail new salt forms, including mesylate, hydrochloride, tartrate, phosphate, and hemi fumarate salts. The inventions also cover crystalline forms, polymorphs, and hydrates of these new salt forms, emphasizing their use in the manufacture of medicaments for treating specific disorders.
Career Highlights
Throughout her career, Weijia Zheng has worked with notable companies such as Novartis AG and Vernalis (R&D) Limited. Her experience in these organizations has contributed to her expertise in pharmaceutical research and development.
Collaborations
Weijia has collaborated with esteemed colleagues, including Martin James Drysdale and Brian William Dymock, enhancing her research through teamwork and shared knowledge.
Conclusion
Weijia Zheng's innovative work in pharmaceutical chemistry and her contributions to the development of new medicinal formulations highlight her role as a significant inventor in the field. Her patents and collaborations reflect her commitment to advancing healthcare solutions.